In the BioHarmony Drug Report Database
Golodirsen
Vyondys (golodirsen) is an oligonucleotide pharmaceutical. Golodirsen was first approved as Vyondys on 2019-12-12. It is used to treat duchenne muscular dystrophy in the USA. Vyondys 53’s patents are valid until 2025-06-28 (FDA).
Trade Name
|
Vyondys |
|---|---|
Common Name
|
golodirsen |
ChEMBL ID
|
CHEMBL4297762 |
Indication
|
duchenne muscular dystrophy |
Drug Class
|
Antisense oligonucleotides |
Image (chem structure or protein)
